Assessment of prion reduction filters in decreasing infectivity of ultracentrifuged 263K scrapie-infected brain homogenates in "spiked" human blood and red blood cells

Transfusion

Volumn 54, Issue 4, 2014, Pages 990-995

  Cardone, Franco ^a   Sowemimo Coker, Samuel ^b   Abdel Haq, Hanin ^a   Sbriccoli, Marco ^a   Graziano, Silvia ^a   Valanzano, Angelina ^a   Berardi, Vito Angelo ^a   Galeno, Roberta ^a   Puopolo, Maria ^a   Pocchiari, Maurizio ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b HAEMONETICS CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOASSAY; BLOOD CELL; BLOOD FILTER; BLOOD TRANSFUSION; BRAIN HOMOGENATE; DISEASE TRANSMISSION; ERYTHROCYTE; HAMSTER; HUMAN; HUMAN CELL; INFECTION RISK; INFECTION SENSITIVITY; NONHUMAN; PRION REDUCTION FILTER; RISK ASSESSMENT; SCRAPIE; SUPERNATANT; ULTRACENTRIFUGATION; VARIANT CREUTZFELDT JAKOB DISEASE; VIRUS SPIKE;

ANIMALS; BRAIN; CRICETINAE; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; FILTRATION; HUMANS; MICROPORE FILTERS; PRIONS; SCRAPIE; ULTRACENTRIFUGATION;

EID: 84898843343     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12369     Document Type: Article

References (24)

1. Knight R,. The risk of transmitting prion disease by blood or plasma products. Transfus Apher Sci 2010; 43: 387-391.
2. Gregori L, McCombie N, Palmer D, Birch P, Sowemimo-Coker SO, Giulivi A, Rohwer RG,. Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood. Lancet 2004; 364: 529-531. (Pubitemid 39070414)
3. Sowemimo-Coker S, Kascsak R, Kim A, Andrade F, Pesci S, Kascsak R, Meeker C, Carp R, Brown P,. Removal of exogenous (spiked) and endogenous prion infectivity from red cells with a new prototype of leukoreduction filter. Transfusion 2005; 45: 1839-1844. (Pubitemid 43971410)
4. McCutcheon S, Alejo Blanco AR, Houston EF, de Wolf C, Tan BC, Smith A, Groschup MH, Hunter N, Hornsey VS, MacGregor IR, Prowse CV, Turner M, Manson JC,. All clinically-relevant blood components transmit prion disease following a single blood transfusion: a sheep model of vCJD. PloS ONE 2011; 6: e23169.
5. Lacroux C, Bougard D, Litaise C, Simmons H, Corbiere F, Dernis D, Tardivel R, Morel N, Simon S, Lugan S, Costes P, Weisbecker JL, Schelcher F, Grassi J, Coste J, Andréoletti O,. Impact of leucocyte depletion and prion reduction filters on TSE blood borne transmission. PloS ONE 2012; 7: e42019.
6. Brown P, Cervenáková L, McShane LM, Barber P, Rubenstein R, Drohan WN,. Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. Transfusion 1999; 39: 1169-1178.
7. Holada K, Vostal JG, Theisen PW, MacAuley C, Gregori L, Rohwer RG,. Scrapie infectivity in hamster blood is not associated with platelets. J Virol 2002; 76: 4649-4650. (Pubitemid 34309601)
8. Cervenáková L, Yakovleva O, McKenzie C, Kolchinsky S, McShane L, Drohan WN, Brown P,. Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy. Transfusion 2003; 43: 1687-1694. (Pubitemid 37518076)
9. Yakovleva O, Janiak A, McKenzie C, McShane L, Brown P, Cervenáková L,. Effect of protease treatment on plasma infectivity in variant Creutzfeldt-Jakob disease mice. Transfusion 2004; 44: 1700-1705. (Pubitemid 39644053)
10. Houston F, McCutcheon S, Goldmann W, Chong A, Foster J, Sisõ S, González L, Jeffrey M, Hunter N,. Prion diseases are efficiently transmitted by blood transfusion in sheep. Blood 2008; 112: 4739-4745.
11. Mathiason CK, Hayes-Klug J, Hays SA, Powers J, Osborn DA, Dahmes SJ, Miller KV, Warren RJ, Mason GL, Telling GC, Young AJ, Hoover EA,. B cells and platelets harbor prion infectivity in the blood of deer infected with chronic wasting disease. J Virol 2010; 84: 5097-5107.
12. UK Department of Health. Advisory Committee on Dangerous Pathogens. Annual report for 2012, ACDP/100/P7a. February 2013. [cited 2013 Jul 23]: http://www.hse.gov.uk/aboutus/meetings/committees/acdp/ar2012.pdf
13. Gregori L, Lambert BC, Gurgel PV, Gheorghiu L, Edwardson P, Lathrop JT, Macauley C, Carbonell RG, Burton SJ, Hammond D, Rohwer RG,. Reduction of transmissible spongiform encephalopathy infectivity from human red blood cells with prion protein affinity ligands. Transfusion 2006; 46: 1152-1161. (Pubitemid 44139489)
14. Gregori L, Gurgel PV, Lathrop JT, Edwardson P, Lambert BC, Carbonell RG, Burton SJ, Hammond DJ, Rohwer RG,. Reduction in infectivity of endogenous transmissible spongiform encephalopathies present in blood by adsorption to selective affinity resins. Lancet 2006; 368: 2226-2230. (Pubitemid 44959015)
15. Sowemimo-Coker SO, Pesci S, Andrade F, Kim A, Kascsak RB, Kascsak RJ, Meeker C, Carp R,. Pall leukotrap affinity prion-reduction filter removes exogenous infectious prions and endogenous infectivity from red cell concentrates. Vox Sang 2006; 90: 265-275.
16. Sowemimo-Coker SO, Demczyk CA, Andrade F, Baker CA,. Evaluation of removal of prion infectivity from red blood cells with prion reduction filters using a new rapid and highly sensitive cell culture-based infectivity assay. Transfusion 2010; 50: 980-988.
17. Cardone F, Simoneau S, Arzel A, Puopolo M, Berardi VA, Abdel-Haq H, Galeno R, De Pascalis A, Sbriccoli M, Graziano S, Valanzano A, Porte P, Diringer H, Brown P, Flan B, Pocchiari M,. Comparison of nanofiltration efficacy in reducing infectivity of centrifuged versus ultracentrifuged 263K scrapie-infected brain homogenates in "spiked" albumin solutions. Transfusion 2012; 52: 953-962.
18. Berardi VA, Cardone F, Valanzano A, Lu M, Pocchiari M,. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation. Transfusion 2006; 46: 652-658.
19. Coste J, Prowse C, Grabmer C, Schennach H, Santos Prado Scuracchio P, Wendel SN, Germain M, Delage G, Krusius T, Ekblom-Kullberg S, Tiberghien P, O'Riordan J, Murphy WG, Flesland O, Turner M, Williamson L, Gregori L, Epstein J, Asher D, Panzer S, Reesink HW,. Prion reduction of red-blood-cells. Vox Sang 2012; 103: 260-272.
20. Wiltshire M, Cardigan R, Thomas S,. Manufacture of red cells in additive solution from whole blood refrigerated for 5 days or remanufactured from red cells stored in plasma. Transfus Med 2010; 20: 383-391.
21. Wiltshire M, Thomas S, Scott J, Hicks V, Haines M, Cookson P, Garwood M, Cardigan R,. Prion reduction of red blood cells: impact on component quality. Transfusion 2010; 50: 970-979.
22. Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, Caughey B,. The most infectious prion protein particles. Nature 2005; 437: 257-261. (Pubitemid 41294488)
23. Molesworth AM, Mackenzie J, Everington D, Knight RS, Will RG,. Sporadic Creutzfeldt-Jakob disease and risk of blood transfusion in the United Kingdom. Transfusion 2011; 51: 1872-1873.
24. Puopolo M, Ladogana A, Vetrugno V, Pocchiari M,. Transmission of sporadic Creutzfeldt-Jakob disease by blood transfusion: risk factor or possible biases. Transfusion 2011; 51: 1556-1566.